查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837205

注射器市场按类型、材质、技术和产能划分－2025-2032年全球预测

Syringes Market by Type, Material, Technology, Volume - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，注射器市场规模将成长至 157.1 亿美元，复合年增长率为 4.91%。

关键市场统计数据
基准年2024年 107亿美元
预计年份：2025年 112.3亿美元
预测年份 2032 157.1亿美元
复合年增长率 (%) 4.91%

简明扼要地介绍了不断变化的临床需求、监管压力、生产转变以及注射器行业相关人员的策略要务。

临床、技术和政策因素正在重塑注射器医疗服务格局，要求製造商、采购人员和医疗服务提供者做出明智的应对。临床需求不断演变，重点转向生技药品输送、扩大免疫接种计划以及家庭护理疗法的兴起，这些都要求注射器具备安全性、易用性和适合自我给药的特点。同时，世界各地的监管机构正在加强对器械安全性、上市后监管和环境影响的审查，迫使製造商重新思考器械的设计、材料选择和使用寿命。

在製造方面，资本密集和品质要求推动了对自动化和製程检验的投资，而近期全球事件暴露出的供应链脆弱性则凸显了冗余和近岸外包的重要性。技术创新正在拓展注射器的功能定义：从简单的液体输送到包含预填充剂型、安全机制和连接功能的整合式药物装置系统，以支援患者依从性和药物安全检测。总而言之，这些压力共同造就了这样一种局面：策略清晰度、营运灵活性和跨职能协作是维持持续竞争力的先决条件。本引言为后续的深入分析奠定了基础，重点在于相关人员如何应对和塑造临床应用、製造和监管等领域的新兴优先事项。

权威分析揭示了技术、永续性、监管和供应链的变化如何重塑注射器产业及其竞争动态。

注射剂产业正经历一场变革性的转变，这场转变超越了产品渐进式升级，涵盖了给药装置设计、製造和分销方式的系统性变革。技术进步正在加速从传统标准注射器向差异化产品的过渡，例如预填充系统、安全装置和智慧注射器，这些智慧注射器整合了感测器和连接功能，以支援依从性追踪和药物警戒。这些创新并非孤立的产品迭代，而是材料科学、器材工程和数位化能力的整合，共同重新定义了支付方和医疗服务提供者的价值提案。

同时，永续性和生命週期的考量正促使人们重新评估材料和废弃物管理策略，这影响着采购决策和监管预期。在供应链方面，在地化和多区域产能提升的趋势日益显着，以降低集中中断和关税相关不确定性所带来的风险。製造业正变得更加自动化和模组化，从而能够更快地切换产品类型并满足契约製造的需求。最后，商业化模式也变得更加协作，医疗器材製造商、製药公司和服务供应商携手合作，开发组合产品和整合服务。这些趋同的转变将催生新的赢家，并扩大那些未能及时调整产品开发、监管和供应链模式的企业的竞争差距。

全面评估2025年美国关税如何影响注射器价值链的采购决策、生产在地化、定价权和供应链韧性

2025年美国关税政策对注射器生态系统的成本结构、筹资策略和供应链设计产生了连锁反应。製造商和采购商迅速应对贸易格局的变化，重新评估供应商关係，加快对国内或近岸产能的投资，并调整采购框架以应对更高的到岸成本。对一些公司而言，关税强化了现有的在地化生产和关键流程垂直整合计画。而对其他公司而言，关税则使其迫切需要实现供应商多元化，并为关键零件实施避险策略。

累积效应也改变了现有全球和区域製造商之间的竞争动态。对国内生产的投资提高了韧性，但也带来了与扩大高品质、合规生产规模相关的资本和营运挑战。同时，经销商和医疗保健提供者重新审视了合约条款和库存策略，以减轻短期价格波动和潜在的供不应求。随着相关人员寻求明确关税分类、豁免和可能减轻过渡期负担的政策应对措施，监管方面的参与度也随之提高。总而言之，这些发展重塑了谈判动态，促进了部分层级的供应商整合，并强调了透明、审核的供应链的重要性，以便在更复杂的贸易环境下证明产品的原产地、可追溯性和合规性。

深入的細項分析揭示了产品类型、材料、技术和生产规模如何相互交织，从而驱动临床相关性、生产策略和商业性差异化。

基于细分市场的观点为理解价值、风险和创新在产品和工艺层面的集中位置提供了一个结构化的框架。按类型划分，抛弃式器材和可重复使用医疗器材的市场细分清晰地展现了成本与临床应用之间的权衡。当感染控制、便利性和监管简单性至关重要时，一次性医疗器材是首选；而在某些机构中，生命週期成本、灭菌通讯协定和材料耐用性是优先考虑因素，可抛弃式使用系统仍然具有重要意义。按材料划分，玻璃、塑胶和不銹钢之间的选择不仅取决于生技药品和阻隔性能等功能属性，还取决于製造复杂性和使用后的物料输送。玻璃通常用于某些生技药品和预填充产品，塑胶具有一次性使用的便利性和成本效益，而不銹钢则与工业环境中的可重复使用性和耐用性有关。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 为了防止医疗机构发生针刺伤，采用安全设计的自动失效注射器的做法正在推广。
  • 生物製药和疫苗给药领域对预填充玻璃容器的需求不断增长
  • 低收入国家正日益限制使用一次性自毁式註射器，以遏止疾病传播。
  • 智慧注射器的出现，透过物联网驱动的剂量追踪和使用情况监测，提高了病患的用药依从性。
  • 在一次性注射器的生产中，逐步过渡到使用环保生物分解性塑胶和不含乳胶的材料。
  • 对用于无痛给药的微针贴片和无针注射技术的投资不断增长
  • 皮下给药系统的普及性推动了预填充注射笔和注射器在慢性病治疗中的广泛应用。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 注射器市场（按类型划分）

  • 一次性的
  • 可重复使用的

第九章 注射器市场：依材质

  • 玻璃
  • 塑胶
  • 不銹钢

第十章 注射器市场：依技术划分

  • 预填充
    • 自动喷油器
    • 墨水匣
  • 安全
    • 积极的
    • 被动的
  • 聪明的
  • 标准

第十一章 注射器市场：依容量划分

  • 大容量
  • 低容量
  • 中等容量

第十二章 各地区注射器市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 注射器市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国注射器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Angiplast Pvt. Ltd.
    • Cartel Healthcare Pvt. Ltd
    • Becton, Dickinson and Company
    • GlaxoSmithKline plc
    • AbbVie Inc.
    • Pfizer, Inc.
    • Sanofi SA
    • Novartis AG
    • Eli Lilly and Company
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
Product Code: MRR-034B50030947

The Syringes Market is projected to grow by USD 15.71 billion at a CAGR of 4.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 10.70 billion
Estimated Year [2025] USD 11.23 billion
Forecast Year [2032] USD 15.71 billion
CAGR (%) 4.91%

A concise orienting introduction that frames evolving clinical demands, regulatory pressures, manufacturing shifts, and the strategic imperatives for syringe industry stakeholders

The healthcare delivery environment for syringes is being reshaped by converging clinical, technological, and policy forces that require informed responses from manufacturers, procurement professionals, and healthcare providers. Clinical demand continues to evolve with a growing emphasis on biologics delivery, expanded immunization programs, and the rise of homecare therapies that favor devices designed for safety, ease of use, and compatibility with self-administration. Concurrently, regulatory bodies worldwide are intensifying scrutiny on device safety, post-market surveillance, and environmental impact, prompting manufacturers to rethink design, materials selection, and end-of-life considerations.

On the manufacturing side, capital intensity and quality requirements are driving investments in automation and process validation, while supply chain fragilities revealed by recent global events have elevated the importance of redundancy and nearshoring. Technological innovation is expanding the definition of what a syringe can do: from simple fluid delivery to integrated drug-device systems that include prefilled formats, safety mechanisms, and connectivity that supports adherence and pharmacovigilance. Taken together, these pressures create a landscape where strategic clarity, operational flexibility, and cross-functional coordination are prerequisites for sustained competitiveness. This introduction establishes the framing for deeper analysis that follows, centering on how stakeholders can respond to and shape the emerging priorities across clinical use, manufacturing, and regulation.

An authoritative analysis of the convergent technological, sustainability, regulatory, and supply chain shifts that are remaking the syringe industry and competitive dynamics

The syringe sector is experiencing transformative shifts that extend beyond incremental product upgrades to encompass systemic change in how delivery devices are designed, manufactured, and distributed. Technological advancements are accelerating the transition from traditional standard syringes to differentiated offerings such as prefilled systems, safety-enabled devices, and smart syringes that embed sensors or connectivity to support adherence tracking and drug safety monitoring. These innovations are not isolated product iterations but represent an integration of materials science, device engineering, and digital capabilities that together redefine value propositions for payers and providers.

At the same time, sustainability and lifecycle considerations are prompting re-evaluation of materials and waste management strategies, which influences both procurement decisions and regulatory expectations. On the supply chain front, there is a discernible shift toward regionalization and capacity building in multiple geographies to reduce exposure to single-point disruptions and tariff-related uncertainties. Manufacturing is becoming more automated and modular, enabling faster changeovers between product types and greater responsiveness to contract manufacturing demand. Finally, commercialization models are becoming more collaborative, with device manufacturers, pharmaceutical companies, and service providers co-developing combination products and integrated service offerings. These convergent shifts are creating new winners and widening the competitive gap for players that cannot adapt their product development, regulatory, and supply chain models in a timely manner.

A comprehensive evaluation of how 2025 United States tariff measures reshaped sourcing decisions, manufacturing localization, pricing dynamics, and supply chain resilience across the syringe value chain

The tariff actions introduced in the United States in 2025 have had a cascading influence on cost structures, sourcing strategies, and supply chain design across the syringe ecosystem. Manufacturers and buyers responded quickly to the changed trade calculus by reassessing supplier relationships, accelerating investments in domestic or nearshore capacity, and adjusting procurement frameworks to incorporate higher landed costs. For some firms, the tariffs intensified existing plans to localize production and vertically integrate critical processes, while for others they created an immediate need to diversify suppliers and implement hedging strategies for critical components.

The cumulative impact also altered competitive dynamics between established global manufacturers and regional producers. Domestic production investments improved resilience but introduced capital and operational challenges related to scaling high-quality, regulatory-compliant manufacturing. In parallel, distributors and healthcare providers re-examined contract terms and inventory strategies to mitigate short-term price volatility and potential availability gaps. Regulatory engagement increased as stakeholders sought clarity on tariff classifications, exemptions, and potential policy responses that could ease transitional burdens. Taken together, these developments reshaped negotiation dynamics, encouraged supplier consolidation in some tiers, and placed a premium on transparent, auditable supply chains capable of demonstrating origin, traceability, and compliance under more complex trade conditions.

Insightful segmentation analysis revealing how intersections of type, material, technology, and production volume drive clinical relevance, manufacturing strategy, and commercial differentiation

Segmentation-based perspectives provide a structured lens to understand where value, risk, and innovation are concentrated across product and process dimensions. Based on Type, the market delineation between Disposable and Reusable devices highlights distinct cost and clinical-use trade-offs: disposable formats are favored where infection control, convenience, and regulatory simplicity matter most, while reusable systems retain relevance in specific institutional contexts where lifecycle cost, sterilization protocols, and material robustness are prioritized. Based on Material, choices among Glass, Plastic, and Stainless Steel influence not only functional attributes such as compatibility with biologics and barrier performance but also manufacturing complexity and end-of-life handling; glass often remains preferred for certain biologic formulations and prefilled formats, plastics dominate single-use convenience and cost efficiencies, and stainless steel is associated with durability in reusable or industrial settings.

Based on Technology, the segmentation across Prefill, Safety, Smart, and Standard reflects how device differentiation maps to end-user needs and regulatory burden. The Prefill category bifurcates into Auto Injector and Cartridge formats, each with distinct user-experience and fill-finish implications; auto injectors prioritize ergonomics and self-administration, while cartridge-based systems support modularity and ease of pairing with multiple delivery mechanisms. The Safety category further divides into Active and Passive mechanisms, with active safety devices requiring user engagement to deploy protective features and passive designs integrating automatic protection to reduce reliance on training. Smart syringes are emerging as a high-value niche where embedded connectivity and sensors provide adherence data and pharmacovigilance signals, whereas standard syringes continue to serve high-volume, low-complexity use cases. Based on Volume, differentiation among High Volume, Medium Volume, and Low Volume production runs informs manufacturing strategy, with high-volume production leveraging economies of scale and automation while low-volume, specialty production demands flexible manufacturing and tighter quality oversight. Viewing the market through these intersecting segmentation lenses clarifies which combinations of design, material, and technology are most attractive to specific clinical use-cases and commercial channels, and it underscores where investment in tooling, regulatory evidence, and supply chain capabilities will generate disproportionate returns.

A regionally nuanced appraisal of demand drivers, regulatory environments, and manufacturing roles across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence strategic choices

Regional dynamics shape demand profiles, regulatory expectations, and manufacturing strategies in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, mature healthcare systems, large biologics pipelines, and a robust homecare market drive demand for advanced delivery devices and prefilled formats; procurement cycles in this region are strongly influenced by payer dynamics, hospital group purchasing, and stringent post-market surveillance requirements. Meanwhile, Europe, Middle East & Africa exhibits a diverse set of regulatory regimes and procurement models where harmonization efforts and safety-focused policy initiatives create incentives for safety syringes and traceability solutions, while varying levels of reimbursement and infrastructure influence adoption speed across subregions.

Asia-Pacific is characterized by a pronounced manufacturing footprint and rapidly evolving demand patterns. The region continues to expand its role as a production hub, driven by cost advantages, scaling capacity, and targeted investment in high-volume manufacturing, even as domestic markets increasingly demand more sophisticated delivery systems. Across all regions, there is an emergent focus on regional supply chain resilience, regulatory alignment for combination products, and environmentally responsible waste management. These regional contours imply that successful commercial strategies will be tailored to local regulatory timelines, procurement behaviors, and manufacturing capabilities, while also leveraging cross-border synergies for innovation and capacity optimization.

Strategic company-level insights showing how innovation, manufacturing scale, supply chain resilience, and regulatory positioning determine competitive advantage in the syringe sector

Competitive dynamics among companies operating in the syringe space are increasingly defined by the ability to integrate product innovation with scalable manufacturing and compliant quality systems. Leading firms are investing in automation and process controls to reduce per-unit variability and to meet stringent regulatory evidence requirements for combination products. Partnerships and contract manufacturing relationships are being used strategically to extend capacity while managing capital intensity, enabling original equipment manufacturers to focus on core device innovation and clinical evidence generation. Companies are also differentiating through technology platforms that support prefilled systems, safety mechanisms, and digital adjuncts, thereby creating higher barriers to entry for commoditized segments.

On the commercial front, firms are pursuing segmentation strategies that align product portfolios with customer procurement models, such as hospital systems that prioritize safety and disposable convenience versus specialty clinics that require reusable or high-precision delivery formats. Supply chain resilience has become a competitive axis, with companies emphasizing supplier diversification, localized sourcing, and traceability systems to reassure customers and regulators. In addition, environmental stewardship in materials selection and waste reduction is emerging as a reputational and contractual lever, particularly in jurisdictions with stricter waste management rules. Collectively, these strategic moves highlight that the most successful companies will marry technological differentiation with operational excellence and regulatory foresight.

Actionable, prioritized recommendations for manufacturers, suppliers, and healthcare customers to strengthen resilience, accelerate innovation, and capture strategic value in syringe delivery solutions

Industry leaders should adopt a pragmatic set of actions to secure competitive advantage in an increasingly complex environment. First, diversifying sourcing and building regional production or qualified partnerships will reduce exposure to trade disruptions and tariff volatility while improving responsiveness to local regulatory requirements. Second, prioritizing investment in automation and modular manufacturing enables both cost control for high-volume runs and flexibility for smaller, specialized production lines. Third, accelerating development of prefilled, safety, and smart delivery options will capture emerging clinical and payer preferences, but such efforts must be paired with robust clinical evidence and lifecycle management plans to streamline regulatory approvals and adoption.

Furthermore, embedding sustainability goals into product design and packaging reduces long-term regulatory and disposal risks while addressing growing customer expectations. Equally important is cultivating strategic alliances with pharmaceutical companies and contract manufacturers to co-develop drug-device combinations that improve time-to-market and share commercialization risk. Leadership teams should also strengthen product traceability and digital data capabilities to support pharmacovigilance and value-based contracting conversations. Finally, proactive engagement with regulators and purchasers to clarify standards, secure procurement commitments, and pilot innovative delivery solutions will accelerate adoption and de-risk investments.

A transparent explanation of the mixed-methods research approach combining primary expert engagement, secondary evidence synthesis, and analytical validation to ensure rigorous and actionable insights

The research underpinning this analysis employs a mixed-methods approach combining primary qualitative engagement with industry stakeholders and structured secondary data synthesis to ensure robust, triangulated findings. Primary inputs included in-depth interviews with engineers, regulatory specialists, procurement leaders, and senior operations executives, which provided granularity on manufacturing constraints, regulatory timelines, and customer preferences. Secondary research comprised a careful review of regulatory guidance documents, patent activity, peer-reviewed clinical literature, and supplier technical specifications to validate emergent technology trends and materials performance profiles.

Analytical techniques included supply chain mapping to identify single points of failure and cost drivers, technology readiness assessments to evaluate maturity of prefilled and smart delivery platforms, and scenario-based analysis to understand how trade policy changes and regional capacity expansion could influence sourcing decisions. Quality control procedures included cross-validation of interview insights against independent documentation and iterative feedback loops with subject-matter experts to refine interpretations. This layered methodology yields findings that are both practically oriented and defensible, enabling stakeholders to make informed strategic decisions grounded in a synthesis of empirical evidence and expert judgment.

A concise concluding synthesis that distills strategic imperatives, operational priorities, and the evidence-based rationale for informed decision-making across the syringe ecosystem

In sum, the syringe landscape is at an inflection point where technology progression, regulatory focus, and supply chain reconfiguration converge to redefine industry norms. Devices that combine safety, user-centric design, and regulatory-compliant evidence will increasingly command premium positioning, while manufacturers that invest in flexible, automated production and resilient supplier networks will be better placed to capture emerging opportunities. Trade and policy shifts have underscored the importance of strategic localization and transparent supply chains, elevating operational resilience as a strategic priority alongside innovation.

As stakeholders evaluate next steps, clarity around segment-specific value propositions, targeted regional strategies, and disciplined execution of manufacturing investments will differentiate success from stagnation. The findings summarized in this executive brief aim to provide a practical roadmap for aligning product portfolios, commercial models, and operational capabilities with the evolving needs of healthcare systems, payers, and patients. By acting on the evidence-based recommendations and maintaining active engagement with regulatory and procurement stakeholders, organizations can convert current disruptions into sustained competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of safety-engineered auto-disable syringes to prevent needlestick injuries in healthcare settings
  • 5.2. Increasing demand for prefilled glass syringes in biologic drug administration and vaccine delivery
  • 5.3. Rising regulatory mandates for single-use auto-disable syringes in low-income countries to curb disease transmission
  • 5.4. Emergence of smart syringes with IoT-enabled dose tracking and usage monitoring for improved patient compliance
  • 5.5. Shift towards eco-friendly biodegradable plastics and latex-free materials in disposable syringe manufacturing
  • 5.6. Expanding investment in microneedle patch and needle-free injection technologies for pain-free drug delivery
  • 5.7. Surge in subcutaneous delivery systems driving prefillable pen and syringe uptake for chronic disease therapies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Syringes Market, by Type

  • 8.1. Disposable
  • 8.2. Reusable

9. Syringes Market, by Material

  • 9.1. Glass
  • 9.2. Plastic
  • 9.3. Stainless Steel

10. Syringes Market, by Technology

  • 10.1. Prefill
    • 10.1.1. Auto Injector
    • 10.1.2. Cartridge
  • 10.2. Safety
    • 10.2.1. Active
    • 10.2.2. Passive
  • 10.3. Smart
  • 10.4. Standard

11. Syringes Market, by Volume

  • 11.1. High Volume
  • 11.2. Low Volume
  • 11.3. Medium Volume

12. Syringes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Syringes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Syringes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Angiplast Pvt. Ltd.
    • 15.3.2. Cartel Healthcare Pvt. Ltd
    • 15.3.3. Becton, Dickinson and Company
    • 15.3.4. GlaxoSmithKline plc
    • 15.3.5. AbbVie Inc.
    • 15.3.6. Pfizer, Inc.
    • 15.3.7. Sanofi S.A.
    • 15.3.8. Novartis AG
    • 15.3.9. Eli Lilly and Company
    • 15.3.10. Terumo Corporation
    • 15.3.11. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SYRINGES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SYRINGES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SYRINGES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SYRINGES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SYRINGES MARKET SIZE, BY VOLUME, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SYRINGES MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS SYRINGES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. SYRINGES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. SYRINGES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SYRINGES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SYRINGES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SYRINGES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SYRINGES MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SYRINGES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SYRINGES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SYRINGES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SYRINGES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SYRINGES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SYRINGES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SYRINGES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SYRINGES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYRINGES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SYRINGES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SYRINGES MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SYRINGES MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SYRINGES MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SYRINGES MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SYRINGES MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SYRINGES MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SYRINGES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SYRINGES MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SYRINGES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SYRINGES MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SYRINGES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SYRINGES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SYRINGES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SYRINGES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SYRINGES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SYRINGES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SYRINGES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SYRINGES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SYRINGES MARKET SIZE, BY PREFILL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SYRINGES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SYRINGES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SYRINGES MARKET SIZE, BY AUTO INJECTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SYRINGES MARKET SIZE, BY AUTO INJECTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SYRINGES MARKET SIZE, BY AUTO INJECTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SYRINGES MARKET SIZE, BY AUTO INJECTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SYRINGES MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SYRINGES MARKET SIZE, BY CARTRIDGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SYRINGES MARKET SIZE, BY CARTRIDGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SYRINGES MARKET SIZE, BY CARTRIDGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SYRINGES MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SYRINGES MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SYRINGES MARKET SIZE, BY SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SYRINGES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SYRINGES MARKET SIZE, BY ACTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SYRINGES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SYRINGES MARKET SIZE, BY ACTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SYRINGES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SYRINGES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SYRINGES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SYRINGES MARKET SIZE, BY PASSIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SYRINGES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SYRINGES MARKET SIZE, BY PASSIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SYRINGES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SYRINGES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SYRINGES MARKET SIZE, BY SMART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SYRINGES MARKET SIZE, BY SMART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SYRINGES MARKET SIZE, BY SMART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SYRINGES MARKET SIZE, BY SMART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SYRINGES MARKET SIZE, BY SMART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SYRINGES MARKET SIZE, BY SMART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SYRINGES MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SYRINGES MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SYRINGES MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SYRINGES MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SYRINGES MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SYRINGES MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SYRINGES MARKET SIZE, BY HIGH VOLUME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SYRINGES MARKET SIZE, BY HIGH VOLUME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SYRINGES MARKET SIZE, BY HIGH VOLUME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SYRINGES MARKET SIZE, BY HIGH VOLUME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SYRINGES MARKET SIZE, BY HIGH VOLUME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SYRINGES MARKET SIZE, BY HIGH VOLUME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SYRINGES MARKET SIZE, BY LOW VOLUME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SYRINGES MARKET SIZE, BY LOW VOLUME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SYRINGES MARKET SIZE, BY LOW VOLUME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SYRINGES MARKET SIZE, BY LOW VOLUME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SYRINGES MARKET SIZE, BY LOW VOLUME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SYRINGES MARKET SIZE, BY LOW VOLUME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SYRINGES MARKET SIZE, BY MEDIUM VOLUME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SYRINGES MARKET SIZE, BY MEDIUM VOLUME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SYRINGES MARKET SIZE, BY MEDIUM VOLUME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SYRINGES MARKET SIZE, BY MEDIUM VOLUME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SYRINGES MARKET SIZE, BY MEDIUM VOLUME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SYRINGES MARKET SIZE, BY MEDIUM VOLUME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS SYRINGES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS SYRINGES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 243. GCC SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GCC SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GCC SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 248. GCC SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 249. GCC SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. GCC SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. GCC SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 252. GCC SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 253. GCC SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 254. GCC SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 255. GCC SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 256. GCC SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. BRICS SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. BRICS SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 276. BRICS SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. BRICS SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 280. BRICS SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 281. BRICS SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 282. BRICS SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 285. G7 SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. G7 SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. G7 SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. G7 SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. G7 SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. G7 SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. G7 SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. G7 SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. G7 SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 294. G7 SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 295. G7 SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 296. G7 SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 297. G7 SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 298. G7 SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 299. NATO SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. NATO SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. NATO SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. NATO SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. NATO SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 304. NATO SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 305. NATO SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. NATO SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. NATO SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 308. NATO SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 309. NATO SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 310. NATO SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 311. NATO SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 312. NATO SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED STATES SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED STATES SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED STATES SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED STATES SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED STATES SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED STATES SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED STATES SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED STATES SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 323. UNITED STATES SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED STATES SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED STATES SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED STATES SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 327. CANADA SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. CANADA SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. CANADA SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 330. CANADA SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 331. CANADA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 332. CANADA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 333. CANADA SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 334. CANADA SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 335. CANADA SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 336. CANADA SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 337. CANADA SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 338. CANADA SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 339. MEXICO SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. MEXICO SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. MEXICO SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 342. MEXICO SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 343. MEXICO SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 344. MEXICO SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 345. MEXICO SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 346. MEXICO SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 347. MEXICO SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 348. MEXICO SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 349. MEXICO SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 350. MEXICO SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 351. BRAZIL SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. BRAZIL SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 353. BRAZIL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 354. BRAZIL SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 355. BRAZIL SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 356. BRAZIL SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 357. BRAZIL SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 358. BRAZIL SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 359. BRAZIL SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 360. BRAZIL SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 361. BRAZIL SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 362. BRAZIL SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 363. UNITED KINGDOM SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. UNITED KINGDOM SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 365. UNITED KINGDOM SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 366. UNITED KINGDOM SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 367. UNITED KINGDOM SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 368. UNITED KINGDOM SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 369. UNITED KINGDOM SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 370. UNITED KINGDOM SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 371. UNITED KINGDOM SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 372. UNITED KINGDOM SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 373. UNITED KINGDOM SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 374. UNITED KINGDOM SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 375. GERMANY SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 376. GERMANY SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 377. GERMANY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 378. GERMANY SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 379. GERMANY SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 380. GERMANY SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 381. GERMANY SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 382. GERMANY SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 383. GERMANY SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 384. GERMANY SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 385. GERMANY SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 386. GERMANY SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 387. FRANCE SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 388. FRANCE SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 389. FRANCE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 390. FRANCE SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 391. FRANCE SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 392. FRANCE SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 393. FRANCE SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 394. FRANCE SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 395. FRANCE SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD MILLION)
  • TABLE 396. FRANCE SYRINGES MARKET SIZE, BY SAFETY, 2025-2032 (USD MILLION)
  • TABLE 397. FRANCE SYRINGES MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 398. FRANCE SYRINGES MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 399. RUSSIA SYRINGES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 400. RUSSIA SYRINGES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 401. RUSSIA SYRINGES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 402. RUSSIA SYRINGES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 403. RUSSIA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 404. RUSSIA SYRINGES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 405. RUSSIA SYRINGES MARKET SIZE, BY PREFILL, 2018-2024 (USD MILLION)
  • TABLE 406. RUSSIA SYRINGES MARKET SIZE, BY PREFILL, 2025-2032 (USD MILLION)
  • TABLE 407. RUSSIA SYRINGES MARKET SIZE, BY SAFETY, 2018-2024 (USD